Gritstone bio Inc Key Opinion Leader Webinar on Neoantigen Oncology Programs Transcript
Good morning and welcome to the Gritstone Bio KOL Webinar on Neoantigen Oncology Programs and Colorectal Cancer. (Operator Instructions) As a reminder, this call is being recorded, and a replay will be made available on the Gritstone Bio website following the conclusion of the event.
I'd now like to turn the call over to your host, Dr. Andrew Allen, Co-Founder, President and Chief Executive Officer of Gritstone Bio. Please go ahead, Andrew.
Very good. Thank you, Tara. Good morning, everybody. This is Andrew Allen. I'm the CEO, as you heard, one of the founders of Gritstone Bio, and I'll be making some forward-looking statements during this presentation.
We'll be spending the next hour covering a couple of important topics. I'll begin with a brief overview of the Gritstone Bio neoantigen immunotherapy program with a focus on the personalized program called GRANITE, which will be presenting data at ESMO in September, just a month or so away. I'll give
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |